Loading…
Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study
Background To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes. Methods Fifty-six patients (ages 36 to 85, median 62; 32 fem...
Saved in:
Published in: | European journal of nuclear medicine and molecular imaging 2021-08, Vol.48 (9), p.2914-2924 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3 |
container_end_page | 2924 |
container_issue | 9 |
container_start_page | 2914 |
container_title | European journal of nuclear medicine and molecular imaging |
container_volume | 48 |
creator | Casadaban, Leigh C. Catalano, Paul J. Lee, Leslie K. Hyun, Hyewon Tuncali, Kemal Gerbaudo, Victor H. Shyn, Paul B. |
description | Background
To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes.
Methods
Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT (
n
= 77) and postprocedural MRI (
n
= 56). Local tumor progression was assessed on all available follow-up imaging (1–49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors.
Results
Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05;
P
= 0.004] for minimum ablation margins < 5 mm.
Conclusion
Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes. |
doi_str_mv | 10.1007/s00259-021-05206-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2487748862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487748862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3</originalsourceid><addsrcrecordid>eNp9kUlPHDEQha2IKCzJH8gBWeKSi6Fsj9t2bmjCEgkpOUzOlru7emjUy8TVjYT483gYAhKHnKoO33u1PMa-SjiVAPaMAJTxApQUYBQUwnxgB7KQXlhwfu-1t7DPDonuAKRTzn9i-1ob461UB-zxnAiJ2mHNY9nFqR0H3se0bgfiY8Mvf1yJeN_WvGvvMfFp7sdEvJ7TVvD7YnW2XIn13NZY8-kWUx-7N5tNGivMKNJ3HnnCKY20wWrKTpymuX74zD42sSP88lKP2J_Li9XyWtz8uvq5PL8RlbZmEt4h2AIr68H6otHGKWOgVAvMN1uHriwboxvbxMK72pWFRV1KA7ZqAKKN-oh92_nmjf7OSFPoW6qw6-KA40xBLZy1C-cKldGTd-jdOKchbxeUWXiQhfYuU2pHVfkkStiETWrz1x6ChLCNJuyiCTma8BxNMFl0_GI9lz3Wr5J_WWRA7wDabN-L6W32f2yfAEjjmZc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2549016398</pqid></control><display><type>article</type><title>Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study</title><source>Springer Nature</source><creator>Casadaban, Leigh C. ; Catalano, Paul J. ; Lee, Leslie K. ; Hyun, Hyewon ; Tuncali, Kemal ; Gerbaudo, Victor H. ; Shyn, Paul B.</creator><creatorcontrib>Casadaban, Leigh C. ; Catalano, Paul J. ; Lee, Leslie K. ; Hyun, Hyewon ; Tuncali, Kemal ; Gerbaudo, Victor H. ; Shyn, Paul B.</creatorcontrib><description>Background
To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes.
Methods
Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT (
n
= 77) and postprocedural MRI (
n
= 56). Local tumor progression was assessed on all available follow-up imaging (1–49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors.
Results
Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05;
P
= 0.004] for minimum ablation margins < 5 mm.
Conclusion
Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-021-05206-5</identifier><identifier>PMID: 33559712</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Ablation ; Cardiology ; Computed tomography ; Imaging ; Liver ; Liver cancer ; Magnetic resonance imaging ; Medical imaging ; Medicine ; Medicine & Public Health ; Miscellanea ; Nuclear Medicine ; Oncology ; Original Article ; Orthopedics ; Positron emission ; Positron emission tomography ; Radiology ; Tomography ; Tumors</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2914-2924</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3</citedby><cites>FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3</cites><orcidid>0000-0003-0538-2151 ; 0000-0002-1105-8852 ; 0000-0003-2466-4787 ; 0000-0002-6132-1700 ; 0000-0002-9060-5489 ; 0000-0001-7388-7253 ; 0000-0002-6252-3427</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33559712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Casadaban, Leigh C.</creatorcontrib><creatorcontrib>Catalano, Paul J.</creatorcontrib><creatorcontrib>Lee, Leslie K.</creatorcontrib><creatorcontrib>Hyun, Hyewon</creatorcontrib><creatorcontrib>Tuncali, Kemal</creatorcontrib><creatorcontrib>Gerbaudo, Victor H.</creatorcontrib><creatorcontrib>Shyn, Paul B.</creatorcontrib><title>Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>Background
To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes.
Methods
Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT (
n
= 77) and postprocedural MRI (
n
= 56). Local tumor progression was assessed on all available follow-up imaging (1–49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors.
Results
Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05;
P
= 0.004] for minimum ablation margins < 5 mm.
Conclusion
Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.</description><subject>Ablation</subject><subject>Cardiology</subject><subject>Computed tomography</subject><subject>Imaging</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Magnetic resonance imaging</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Miscellanea</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Radiology</subject><subject>Tomography</subject><subject>Tumors</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kUlPHDEQha2IKCzJH8gBWeKSi6Fsj9t2bmjCEgkpOUzOlru7emjUy8TVjYT483gYAhKHnKoO33u1PMa-SjiVAPaMAJTxApQUYBQUwnxgB7KQXlhwfu-1t7DPDonuAKRTzn9i-1ob461UB-zxnAiJ2mHNY9nFqR0H3se0bgfiY8Mvf1yJeN_WvGvvMfFp7sdEvJ7TVvD7YnW2XIn13NZY8-kWUx-7N5tNGivMKNJ3HnnCKY20wWrKTpymuX74zD42sSP88lKP2J_Li9XyWtz8uvq5PL8RlbZmEt4h2AIr68H6otHGKWOgVAvMN1uHriwboxvbxMK72pWFRV1KA7ZqAKKN-oh92_nmjf7OSFPoW6qw6-KA40xBLZy1C-cKldGTd-jdOKchbxeUWXiQhfYuU2pHVfkkStiETWrz1x6ChLCNJuyiCTma8BxNMFl0_GI9lz3Wr5J_WWRA7wDabN-L6W32f2yfAEjjmZc</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Casadaban, Leigh C.</creator><creator>Catalano, Paul J.</creator><creator>Lee, Leslie K.</creator><creator>Hyun, Hyewon</creator><creator>Tuncali, Kemal</creator><creator>Gerbaudo, Victor H.</creator><creator>Shyn, Paul B.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0538-2151</orcidid><orcidid>https://orcid.org/0000-0002-1105-8852</orcidid><orcidid>https://orcid.org/0000-0003-2466-4787</orcidid><orcidid>https://orcid.org/0000-0002-6132-1700</orcidid><orcidid>https://orcid.org/0000-0002-9060-5489</orcidid><orcidid>https://orcid.org/0000-0001-7388-7253</orcidid><orcidid>https://orcid.org/0000-0002-6252-3427</orcidid></search><sort><creationdate>20210801</creationdate><title>Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study</title><author>Casadaban, Leigh C. ; Catalano, Paul J. ; Lee, Leslie K. ; Hyun, Hyewon ; Tuncali, Kemal ; Gerbaudo, Victor H. ; Shyn, Paul B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Ablation</topic><topic>Cardiology</topic><topic>Computed tomography</topic><topic>Imaging</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Magnetic resonance imaging</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Miscellanea</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Radiology</topic><topic>Tomography</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casadaban, Leigh C.</creatorcontrib><creatorcontrib>Catalano, Paul J.</creatorcontrib><creatorcontrib>Lee, Leslie K.</creatorcontrib><creatorcontrib>Hyun, Hyewon</creatorcontrib><creatorcontrib>Tuncali, Kemal</creatorcontrib><creatorcontrib>Gerbaudo, Victor H.</creatorcontrib><creatorcontrib>Shyn, Paul B.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Database (1962 - current)</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casadaban, Leigh C.</au><au>Catalano, Paul J.</au><au>Lee, Leslie K.</au><au>Hyun, Hyewon</au><au>Tuncali, Kemal</au><au>Gerbaudo, Victor H.</au><au>Shyn, Paul B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>48</volume><issue>9</issue><spage>2914</spage><epage>2924</epage><pages>2914-2924</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Background
To retrospectively assess liver tumor ablation margins using intraprocedural PET/CT images from FDG PET/CT-guided microwave or cryoablation procedures and to correlate minimum margin measurements with local progression outcomes.
Methods
Fifty-six patients (ages 36 to 85, median 62; 32 females) with 77 FDG-avid liver tumors underwent 60 FDG PET/CT guided, percutaneous microwave, or cryoablation procedures. Single breath-hold PET/CT images were used for intraprocedural assessment of the tumor ablation margin: liver tumors remained visible on PET immediately following ablation; microwave ablation zones were visible using contrast-enhanced CT; cryoablation zones (ice balls) were visible using unenhanced CT. Two readers retrospectively determined ablation margin assessability and measured the minimum ablation margin on intraprocedural PET/CT (
n
= 77) and postprocedural MRI (
n
= 56). Local tumor progression was assessed on all available follow-up imaging (1–49 months, mean 15). Local tumor progression was correlated with PET/CT minimum margin measurements using clustered survival models for 61 tumors.
Results
Minimum ablation margins were more often assessable using intraprocedural PET/CT (≥ 73/77 tumors, 95%) than postprocedural MRI (≤ 35/56 tumors, 63%). In 61 tumors with PET/CT-assessable margins (excluding tumors with overlapping ablations after PET/CT), there was a 6-fold increased risk of local tumor progression [hazard ratio (HR) 6.05;
P
= 0.004] for minimum ablation margins < 5 mm.
Conclusion
Breath-hold PET/CT scans, during PET/CT-guided microwave or cryoablation procedures for FDG-avid liver tumors, enable reliable intraprocedural assessment of the entire tumor ablation margin; a minimum PET/CT ablation margin threshold of 5 mm correlates well with local tumor progression outcomes.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33559712</pmid><doi>10.1007/s00259-021-05206-5</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-0538-2151</orcidid><orcidid>https://orcid.org/0000-0002-1105-8852</orcidid><orcidid>https://orcid.org/0000-0003-2466-4787</orcidid><orcidid>https://orcid.org/0000-0002-6132-1700</orcidid><orcidid>https://orcid.org/0000-0002-9060-5489</orcidid><orcidid>https://orcid.org/0000-0001-7388-7253</orcidid><orcidid>https://orcid.org/0000-0002-6252-3427</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1619-7070 |
ispartof | European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2914-2924 |
issn | 1619-7070 1619-7089 |
language | eng |
recordid | cdi_proquest_miscellaneous_2487748862 |
source | Springer Nature |
subjects | Ablation Cardiology Computed tomography Imaging Liver Liver cancer Magnetic resonance imaging Medical imaging Medicine Medicine & Public Health Miscellanea Nuclear Medicine Oncology Original Article Orthopedics Positron emission Positron emission tomography Radiology Tomography Tumors |
title | Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A40%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20ablation%20margins%20of%20FDG-avid%20liver%20tumors%20during%20PET/CT-guided%20thermal%20ablation%20procedures:%20a%20retrospective%20study&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Casadaban,%20Leigh%20C.&rft.date=2021-08-01&rft.volume=48&rft.issue=9&rft.spage=2914&rft.epage=2924&rft.pages=2914-2924&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-021-05206-5&rft_dat=%3Cproquest_cross%3E2487748862%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-98e076ec790796f3582550b24e20678e8bbf53f7fa698d8b67e3b1507cf00a7a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2549016398&rft_id=info:pmid/33559712&rfr_iscdi=true |